Home >
World Psoriasis Day 2019
2019/10/29
Today, IFPA presents World Psoriasis Day, as an annual day dedicated to people with psoriasis and/or psoriatic arthritis. It has been celebrated on October 29 for more than a decade. On World Psoriasis Day, our member associations and their supporters organise activities around the world to raise awareness of psoriasis.
To see examples of all the activities our members put on in around the world last World Psoriasis Day, visit worldpsoriasisday2018.com.
Aim of World Psoriasis Day
World Psoriasis Day is dedicated to people living with psoriasis or psoriatic arthritis. On October 29, we aim to address their needs:
Raise awareness
Psoriasis affects over 125 million people around the world – not just physically, but also socially, emotionally and financially. World Psoriasis Day aims to raise the profile of this debilitating disease and increase awareness of the effect it has on people’s lives.
Spread information
For many, psoriasis is still a relatively unknown disease. On World Psoriasis Day, IFPA spreads information about psoriasis, dispel common myths and answer questions. They also inform patients about their own condition, so they can feel empowered to speak about it.
Improve access to treatment
On World Psoriasis Day, IFPA lobby to give people with psoriasis better access to appropriate, affordable treatment. That’s why they specifically address key health decision-makers like national governments, policy-makers and healthcare providers that day.
Give the psoriasis community a voice
Many people living with psoriasis may struggle to get the world to listen to their needs. World Psoriasis Day is an opportunity for the psoriasis community to speak out from a common platform – and have its voice heard.
Are there special World Psoriasis Day activities?
Yes! Each year, IFPA member associations organise a wide variety of World Psoriasis Day activities – from small gatherings to large-scale events. Examples of activities include:
Awareness-raising walks or running events
Free information events for the general public
Lectures or seminars held by medical professionals
Handing out flyers and brochures in public places
Drawing competitions
Sending out WPD postcards
Free psoriasis assessment and consultations at hospitals
Activities for children and youth
Photo exhibitions with psoriasis-related themes
Radio or TV interviews with patient leaders or medical experts
Fundraising barbecues, get-togethers or concerts
Outdoor yoga sessions for people with psoriasis
Coverage of World Psoriasis Day by local or national media
Can I join World Psoriasis Day?
Of course! World Psoriasis Day is open to anyone – whether you have psoriasis yourself, know someone who does or simply want to support people living with psoriasis.
To be part of World Psoriasis Day, you can:
Contact your national psoriasis association to find out about their plans for October 29.
Organise an activity yourself. Perhaps your national association isn’t planning anything or you live in a country without an active psoriasis association? Don’t let this stop you! Organising a workshop, an awareness-raising walk, or simply handing out flyers can be a great way to let your community know about World Psoriasis Day. If you organise something, we’d love to hear about it! That way, IFPA can help promote your activity and share some pictures afterwards for our global audience.
Follow IFPA on Facebook or Twitter to get the latest updates on IFPA’s World Psoriasis Day campaigns and plans.
Spread the word about World Psoriasis Day, wear orange and blue on October 29, or reach out to someone from the psoriasis community to let them know you are there for them.
SOURCE: https://ifpa-pso.com/our-actions/world-psoriasis-day/
SPIN Presentation
Recent news
- 2019/10/29 Focus on...
- 2019/08/12 Focus on...
Latin American Clinical Practice Guidelines on the Systemic Treatment of Psoriasis
- 2019/06/03 Focus on...
- 2019/05/21 Focus on...
Prof Nelida Aurora Raimondo
News from the web office
- 2016/10/29
- 2016/05/26
- 2016/02/20
Events
- 2019/04/18 Focus on...
- 2018/02/21
News from medical groups
- 2018/04/18
- 2017/06/21
News from patients associations
- 2017/02/08
- 2016/05/26
Recent publications on Psoriasis and Atopic Dermatitis
on Psoriasis
Loss of keratinocyte Mcpip1 abruptly activates the IL-23/Th17 and Stat3 pathways in skin inflammation.
Biochim Biophys Acta Mol Cell Res.
2021 Jan , 1868, (1):118866.
Strobilanthes cusia (Nees) Kuntze, a multifunctional traditional Chinese medicinal plant, and its herbal medicines: A comprehensive review.
J Ethnopharmacol.
2021 Jan 30, 265:113325.
Strobilanthes cusia (Nees) Kuntze (SCK, Malan), a traditional Chinese medicinal plant, has long applied to detoxification, defervescence, detumescence and antiphlogosis. "Southern Banlangen" (Rhizoma et Radix Baphicacanthis Cusiae, RRBC), root and rhizome of SCK, is widely used for treatment of many epidemic diseases. Malanye (Southern Daqingye), stem and leaf of SCK, is an antipyretic-alexipharmic drug frequently-used in southern China. Qingdai (Indigo Naturalis, IN), a processed product (...)
see on pubmed
In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors.
Acta Pharm.
2021 Mar 01, 71, (1):33-56.
Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn's disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This (...)
see on pubmed
on Atopic Dermatitis
Diet-Induced Mouse Model of Atopic Dermatitis.
Fujii M et al.
Diet-Induced Mouse Model of Atopic Dermatitis.
Methods Mol Biol.
2021 , 2223:79-86.
Atopic dermatitis (AD) is a common skin disease characterized by chronic inflammation and itchiness. Although skin barrier dysfunction and immune abnormalities are thought to contribute to the development of AD, the precise pathogenic mechanism remains to be elucidated. We have developed a unique, diet-induced AD mouse model based on the findings that deficiencies of certain polyunsaturated fatty acids and starches cause AD-like symptoms in hairless mice. Here, we present a protocol and (...)
see on pubmed
Generation and Characterization of Inducible Lung and Skin-Specific IL-22 Transgenic Mice.
Methods Mol Biol.
2021 , 2223:115-132.
IL-22 is an IL-10 family cytokine that is increased in asthma and atopic dermatitis (AD). However, the specific role of IL-22 in the pathogenesis of allergic lung inflammation and AD in vivo has yet to be elucidated. We aimed to develop mouse models of allergic diseases in the lung and skin with inducible and tissue-specific expression of IL-22, using a tetracycline (Tet)-controlled system. In this chapter, we describe a series of protocols we have developed to generate a construct that (...)
see on pubmed
Heterogeneity of Childhood Asthma in Korea: Cluster Analysis of the Korean Childhood Asthma Study Cohort.
Allergy Asthma Immunol Res.
2021 Jan , 13, (1):42-55.
Asthma is a heterogeneous airway disease occurring in children, and it has various clinical phenotypes. A clear differentiation of the clinical phenotypes can provide better asthma management and prediction of asthma prognosis. Little is currently known about asthma phenotypes in Korean children. This study was designed to identify asthma phenotypes in school-aged Korean children.
see on pubmed
